Evidence for a synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raised cholesterol levels. The REGRESS Study Group.
暂无分享,去创建一个
A. Zwinderman | J. Reiber | J. Jukema | A. Van der Laarse | K. Lie | A. V. van Boven | A. V. Bruschke | A. van der Laarse